science wire



Results 451 - 500 of 2631.
« Previous 1 ... 6 7 8 9 10 11 12 13 14 ... 53 Next »

Health - Pharmacology - 01.02.2021
African and Hispanic Americans Report Low Rates of COVID-19 Vaccinations
Daily national surveys by Carnegie Mellon University show Black and Hispanic Americans are far less likely than whites to report that they have received COVID-19 vaccinations. Just 6.4% of African Americans and 6.8% of Hispanic Americans say they have received the vaccines, compared to 9.3% of whites.

Pharmacology - Health - 29.01.2021
Novartis receives positive CHMP opinion for Kesimpta * (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis
  Kesimpta is a targeted B-cell therapy that delivers superior efficacy with a similar safety and tolerability profile compared with teriflunomide, a first-line treatment in MS 1 CHMP opinion is base

Health - Pharmacology - 28.01.2021
UCLA leaders offer facts on COVID-19 vaccine safety and effectiveness at town hall
UCLA administrative and medical leaders provided updated COVID-19 vaccination information and answered faculty and staff questions at an hour-long town hall with nearly 2,000 viewers on Wednesday, Jan.

Health - Pharmacology - 28.01.2021

Health - Pharmacology - 28.01.2021
Researchers Expand Clinical Trials Investigating Convalescent Plasma Therapy for COVID-19
It's hoped the long-used approach, which would use antibody-rich infusions, can either reduce disease symptoms or prevent infections after exposure to SARS-CoV-2 Parallel to COVID-19 vaccination efforts, physicians and researchers at UC San Diego Health, with collaborators across the country, are conducting a pair of clinical trials to assess whether convalescent plasma (CP) therapy can either mitigate symptoms in outpatients with the viral disease or perhaps prevent it after a known exposure.

Health - Pharmacology - 28.01.2021

Health - Pharmacology - 26.01.2021
Belgian initiative for AI lung scan analysis in fight against COVID-19 goes European
Icovid is being rolled out across Europe and is on the OECD shortlist for AI initiatives against current and future pandemics The Belgian initiative icovid, which supports radiologists in the assessm

Pharmacology - Health - 25.01.2021
’Your neighbor is your kin’: How putting others first can help us get through the pandemic
With multiple COVID-19 vaccines approved for emergency use in the United States, one of the biggest challenges of 2021 will be ethically and equitably allocating them to the public.

Health - Pharmacology - 25.01.2021
A treatment for every kind of cancer
A treatment for every kind of cancer
Researchers from the University of Basel have identified cells in the immune system that are able to attack a wide range of cancer cells.

Health - Pharmacology - 25.01.2021
A new ’double’ antibody that protects against Covid-19 and its variations discovered in Ticino
The Institute for Research in Biomedicine (IRB, affiliated to USI Universitą della Svizzera italiana, has developed a second-generation 'double antibody' that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants.

Pharmacology - Social Sciences - 21.01.2021
Randomised trials could help to return children safely to schools - study
Randomised trials could help to return children safely to schools - study
Schools are closing again in response to surging levels of COVID-19 infection, but staging randomised trials when students eventually return could help to clarify uncertainties around when we should send children back to the classroom, according to a new study.

Health - Pharmacology - 20.01.2021
Why are around a third of pregnant women not vaccinated against whooping cough?
Whooping cough is widespread, highly contagious and serious for new-born babies. However, 30 per cent of pregnant women in the UK do not receive the whooping cough vaccine, leading to avoidable illness and death and the Covid-19 pandemic appears to be having a negative impact on these numbers.

Health - Pharmacology - 20.01.2021
Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice
Study supports launch of Phase I clinical trial to test a designer DNA agent - an antisense oligonucleotide that targets a gene called IRF4 - in patients with multiple myeloma Many patients with multiple myeloma, a type of blood cancer, eventually develop resistance to one treatment after another.

Health - Pharmacology - 18.01.2021
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19 | University of Oxford
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Health - Pharmacology - 18.01.2021
Birmingham maternity experts call for urgent action on pregnancy ’drug drought’
Leaders in maternal healthcare have called for lifesaving research into pharmaceuticals for use during pregnancy in a new report highlighting the challenges of pregnancy-related complications, pre-term birth and pre-existing conditions.

Pharmacology - Health - 14.01.2021
Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic spontaneous urticaria (CSU)
Ligelizumab is the first treatment to receive FDA Breakthrough Therapy designation in chronic spontaneous urticaria (CSU) in patients with an inadequate response to H1-antihistamines 1   Currently th

Pharmacology - Health - 12.01.2021
Second COVID-19 vaccine approved for Switzerland
On 12 January 2021 Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, approved the second COVID-19 vaccination for the Swiss market.

Health - Pharmacology - 08.01.2021
Welsh ’wellness’ tea arrives in lockdown
The first batch of a new wellness green tea blended with pure Welsh honey and scientifically identified botanicals has arrived in Wales.

Health - Pharmacology - 06.01.2021
Global experts urge everyone to talk about COVID-19 vaccines responsibly
A team of renowned scientific experts has joined forces from across the world to help fight the spread of misinformation about the COVID-19 vaccines, which hold the key to beating the deadly pandemic and releasing countries from debilitating lockdown restrictions.

Health - Pharmacology - 06.01.2021
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR).

Health - Pharmacology - 05.01.2021
New Ebolavirus treatment sees the light thanks to basic research performed in Ticino
While populations around the world are being vaccinated against SARS-CoV-2, the U.S. Food and Drug Administration has announced the approval of a treament against another well-known virus, much less widespread but extremely lethal: Ebola.

Health - Pharmacology - 22.12.2020
COVID-19: Study with targeted therapy launched in Vienna
A phase II clinical trial for the treatment of patients with COVID-19 is currently starting at the Medical University of Vienna as part of the Austrian CoronaVirus Adaptive Clinical Trial (ACOVACT).

Pharmacology - Health - 19.12.2020
Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland
Vaccine from Pfizer/BioNTech authorised in the rolling review procedure after close scrutiny of the risks and benefits Swissmedic has authorised the vaccine from Pfizer/BioNTech.

Life Sciences - Pharmacology - 18.12.2020
A weather station for epileptic seizure
A weather station for epileptic seizure
The unpredictability of epileptic seizures is a severe handicap for patients.

Health - Pharmacology - 18.12.2020
U-M publishes free guides packed with advice and wisdom from COVID-19 patients, caregivers
Practical tips for COVID-19 hospital and post-hospital care available for anyone to use, and for any hospital or health system to adapt and publish No one likes to venture into a new city or country without a map or guidebook.

Pharmacology - Health - 17.12.2020
Opinion: Coronavirus vaccines - how will we know when life can go back to normal?
The first people have begun to receive vaccines as part of mass vaccination campaigns to immunise people against Covid-19. Excitement is building - finally, the end of the coronavirus crisis is in sight, writes Dr Jasmina Panovska-Griffiths (UCL Epidemiology & Health). Since early December, elderly patients and health workers in 50 hospitals across the UK have been given the vaccine developed by Pfizer and BioNTech.

Health - Pharmacology - 17.12.2020

Health - Pharmacology - 16.12.2020
AI could help cut waiting times for cancer by automating mark-up of patient scans prior to radiotherapy
Doctors at Addenbrooke's Hospital in Cambridge aim to drastically cut cancer waiting times by using artificial intelligence (AI) to automate lengthy radiotherapy preparations.
« Previous 1 ... 6 7 8 9 10 11 12 13 14 ... 53 Next »